School of Medicine
Showing 1-50 of 120 Results
-
Austen Brooks Casey
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioAusten Brooks Casey, PhD, is a postdoctoral scholar in the Department of Anesthesiology, Perioperative and Pain Medicine (advisor: Boris Dov Heifets, MD, PhD). He originates from western North Carolina, and has had a long-standing interest in drug discovery for major depression and schizophrenia, which was invigorated by initial coursework in organic chemistry and biochemistry. Austen trained at Northeastern University (advisor: Raymond G. Booth, PhD) where he studied the medicinal chemistry and pharmacology of novel ligands targeting serotonergic G protein-coupled receptors. Currently, he is investigating neural circuits activated by psychedelic drugs, with the long-term goal of using modern techniques in neuroscience to complement drug design efforts toward the development of novel antidepressant and antipsychotic medications.
-
Arianne Caudal
Postdoctoral Scholar, Cardiovascular Institute
BioDr. Arianne Caudal is a postdoctoral fellow at the Stanford Cardiovascular Institute with research interests in cardiac metabolism, disease modeling, and drug discovery. Dr. Caudal received her PhD in Biochemistry from the University of Washington, after conducting thesis work on mitochondrial metabolism and protein-protein interactions in the heart.
-
Katie Cederberg
Postdoctoral Scholar, Psychiatry
BioDr. Cederberg's primary research interests focus on studying the efficacy and effectiveness of exercise for managing symptoms of restless legs syndrome (RLS) and co-occurring conditions (e.g., periodic limb movements, insomnia). She is currently a Postdoctoral Scholar in the Mignot Lab, where she she devotes her time to conducting research aimed at better understanding the relationship among genetics, proteomics, and the presence of and severity of symptoms related to RLS. Her current research is interested in patient's personal experiences with exercise and RLS as well as the relationship between exercise and proteomic biomarkers of RLS. She received her PhD in Rehabilitation Science from the University of Alabama at Birmingham in December 2020, wherein her dissertation utilized a series of methodological approaches to comprehensively examine the relationship between physical activity and RLS in adults with MS. She plans to utilize her experience and training to develop a line of research for informing exercise prescription parameters specifically for managing symptoms of RLS.
-
Antara Chakravarty
Postdoctoral Scholar, Microbiology and Immunology
BioAntara is a Postdoc in Dr. Priscilla Yang's Lab, where she is exploring small molecule-based targeted protein degradation as an antiviral strategy against structural proteins of flaviviruses. She is also keenly interested in understanding the mechanistic details of virus-induced changes in membrane lipid composition of infected cells, for which she is using hepatitis C virus replicase complex as a model system. Antara received training in molecular virology during her doctoral work in Dr. ALN Rao's Lab at the University of California-Riverside. There she discovered key implications of viral capsid dynamics in the pathogenicity and infectivity of multipartite bromoviruses.
-
Varuna Chander
Postdoctoral Scholar, Genetics
Temp - Non-Exempt, Office of Technology Licensing (OTL)BioDr. Varuna Chander is a postdoctoral researcher specializing in genomics and bioinformatics. She holds a BTech and Masters in Industrial Biotechnology, and has experience in early-stage sequencing product development for 7 years. Dr. Chander earned her PhD in Genetics and Genomics from the Human Genome Sequencing Center at Baylor College of Medicine, where she was awarded the NLM Biomedical Informatics and Data Science Fellowship for three years. Her research focused on investigating the molecular causes of rare diseases and also the relationship between somatic mutations in blood and cardiovascular disease risk. Alongside her research, Dr. Chander collaborated on projects employing computational methods to examine the role of structural variation in genetic diseases. Currently, she works with Michael Snyder to study the genomic basis of complex human diseases using multi-omics and machine learning approaches.
-
Paulami Chatterjee
Postdoctoral Scholar, Pulmonary and Critical Care Medicine
Current Research and Scholarly InterestsMy research involves studying the pathogenic mechanisms underlying the host-pathogen interaction in pulmonary diseases. I am particularly interested in exploring transcriptomic and proteomic changes in Cystic Fibrosis and Asthma patients who develop severe allergic inflammation due to fungal hypersensitivity. Complete understanding of these interaction will help us identify significant fungal virulence factors and help us define clinically relevant targets for therapeutic use.
-
Jingxun Chen
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsUnderstand the molecular impact of sexual interaction on vertebrate organ aging
-
Ming Li (Estella) Chen
Postdoctoral Scholar, Cardiovascular Medicine
BioI am an MD from Chung Shan Medical University, Taiwan. Before coming to Stanford, I obtained my MS degree in epidemiology at Harvard T.H. Chan School of Public Health, Boston, MA, where I completed graduate training in clinical, pharmacologic, and genetic epidemiology, and pursued advanced skills in biostatistics and causal inference.
My past research focused on real-world epidemiology studies using patient registries and national health insurance databases to elucidate the predictors or risk factors of immunologic diseases. For my graduate study, I conducted pharmacoepidemiology studies using electronic health record (EHR) data to elucidate the predictors of anti-drug antibodies development and its correlation to autoimmunity, to identify the generation of immunogenicity that may impact the effectiveness of monoclonal antibody therapies in individuals with autoimmune diseases. I gained experience in genetic data manipulation to investigate polymorphisms in response to monoclonal antibody therapies in asthma patients.
At Stanford, I am involved in research on the identification of molecular determinants of cardiometabolic diseases.
